GlassScriptPhysician profile
Lisa C Stern
NPI 1558585950
$1,774.63
in general payments reported to CMS, 2019-2025
21 companies · $331 in 2025
The $331 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $119 · 2021: $87.23 · 2022: $132 · 2023: $345 · 2024: $404 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $364.02 | 2019-2025 | M-M-R II, Gardasil 9, Vaxneuvance |
| Novo Nordisk INC | $239.70 | 2023-2024 | Wegovy |
| Sanofi-Aventis U.S. LLC | $164.70 | 2024-2025 | |
| Cranial Technologies, INC | $131.31 | 2019-2025 | Doc Band |
| Corium, LLC | $113.88 | 2024-2025 | Azstarys |
| Glaxosmithkline, LLC. | $89.41 | 2019-2023 | Bexsero |
| Sobi, INC | $83.46 | 2019-2023 | |
| Alk-Abello, INC | $78.67 | 2025 | Neffy, Grastek, Ragwitek |
| Sanofi Pasteur INC. | $68.33 | 2023-2025 | |
| Biofire Diagnostics, LLC | $49.72 | 2020 | |
| Seqirus USA INC | $49.01 | 2021-2025 | Flucelvax |
| Abbvie INC. | $46.62 | 2019 | |
| Phadia US INC. | $46.38 | 2019-2025 | Immunocap |
| Cognoa, INC. | $44.02 | 2022 | |
| Genentech USA, INC. | $38.86 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $36.90 | 2024-2025 | |
| Shire North American Group INC | $31.71 | 2019 | |
| Oxford Immunotec USA INC | $29.53 | 2021 | |
| Becton, Dickinson and Company | $24.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.62 | 2023 | |
| Sandoz INC. | $21.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.